Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

View source ↗

Summary

A completed single-cell profiling study of liver-infiltrating immune cells in hepatocellular carcinoma associated with MASLD or hepatitis C infection. The findi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Hepatocellular Carcinoma (HCC), MASLD-HCC | Status: COMPLETED